ID   JAK2_RAT                Reviewed;        1132 AA.
AC   Q62689;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   02-OCT-2024, entry version 206.
DE   RecName: Full=Tyrosine-protein kinase JAK2 {ECO:0000305};
DE            EC=2.7.10.2 {ECO:0000250|UniProtKB:O60674};
DE   AltName: Full=Janus kinase 2;
DE            Short=JAK-2;
GN   Name=Jak2 {ECO:0000312|RGD:2939};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=7607555; DOI=10.1016/0378-1119(95)00041-4;
RA   Duhe R.J., Rui H., Greenwood J.D., Garvey K., Farrar W.L.;
RT   "Cloning of the gene encoding rat JAK2, a protein tyrosine kinase.";
RL   Gene 158:281-285(1995).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-523, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Non-receptor tyrosine kinase involved in various processes
CC       such as cell growth, development, differentiation or histone
CC       modifications. Mediates essential signaling events in both innate and
CC       adaptive immunity. In the cytoplasm, plays a pivotal role in signal
CC       transduction via its association with type I receptors such as growth
CC       hormone (GHR), prolactin (PRLR), leptin (LEPR), erythropoietin (EPOR),
CC       thrombopoietin (THPO); or type II receptors including IFN-alpha, IFN-
CC       beta, IFN-gamma and multiple interleukins. Following ligand-binding to
CC       cell surface receptors, phosphorylates specific tyrosine residues on
CC       the cytoplasmic tails of the receptor, creating docking sites for STATs
CC       proteins. Subsequently, phosphorylates the STATs proteins once they are
CC       recruited to the receptor. Phosphorylated STATs then form homodimer or
CC       heterodimers and translocate to the nucleus to activate gene
CC       transcription. For example, cell stimulation with erythropoietin (EPO)
CC       during erythropoiesis leads to JAK2 autophosphorylation, activation,
CC       and its association with erythropoietin receptor (EPOR) that becomes
CC       phosphorylated in its cytoplasmic domain. Then, STAT5 (STAT5A or
CC       STAT5B) is recruited, phosphorylated and activated by JAK2. Once
CC       activated, dimerized STAT5 translocates into the nucleus and promotes
CC       the transcription of several essential genes involved in the modulation
CC       of erythropoiesis. Part of a signaling cascade that is activated by
CC       increased cellular retinol and that leads to the activation of STAT5
CC       (STAT5A or STAT5B). In addition, JAK2 mediates angiotensin-2-induced
CC       ARHGEF1 phosphorylation. Plays a role in cell cycle by phosphorylating
CC       CDKN1B. Cooperates with TEC through reciprocal phosphorylation to
CC       mediate cytokine-driven activation of FOS transcription. In the
CC       nucleus, plays a key role in chromatin by specifically mediating
CC       phosphorylation of 'Tyr-41' of histone H3 (H3Y41ph), a specific tag
CC       that promotes exclusion of CBX5 (HP1 alpha) from chromatin. Up-
CC       regulates the potassium voltage-gated channel activity of KCNA3.
CC       {ECO:0000250|UniProtKB:O60674}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.2;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000305};
CC       Note=Mn(2+) was used in the in vitro kinase assay but Mg(2+) is likely
CC       to be the in vivo cofactor. {ECO:0000305};
CC   -!- ACTIVITY REGULATION: Regulated by autophosphorylation, can both
CC       activate or decrease activity. Heme regulates its activity by enhancing
CC       the phosphorylation on Tyr-1007 and Tyr-1008.
CC       {ECO:0000250|UniProtKB:O60674, ECO:0000250|UniProtKB:Q62120}.
CC   -!- SUBUNIT: Interacts with IL23R, SKB1 and STAM2 (By similarity).
CC       Interacts with EPOR. Interacts with LYN. Interacts with SIRPA.
CC       Interacts with SH2B1. Interacts with TEC (By similarity). Interacts
CC       with IFNGR2 (via intracellular domain) (By similarity). Interacts with
CC       LEPR (Isoform B) (By similarity). Interacts with HSP90AB1; promotes
CC       functional activation in a heat shock-dependent manner. Interacts with
CC       STRA6 (By similarity). Interacts with ASB2; the interaction targets
CC       JAK2 for Notch-induced proteasomal degradation (By similarity).
CC       {ECO:0000250|UniProtKB:O60674, ECO:0000250|UniProtKB:Q62120}.
CC   -!- INTERACTION:
CC       Q62689; P15127: Insr; NbExp=2; IntAct=EBI-8656708, EBI-7472166;
CC       Q62689; P41499: Ptpn11; NbExp=3; IntAct=EBI-8656708, EBI-7180604;
CC   -!- SUBCELLULAR LOCATION: Endomembrane system {ECO:0000250}; Peripheral
CC       membrane protein {ECO:0000250}. Cytoplasm {ECO:0000250}. Nucleus
CC       {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed throughout most tissues.
CC       {ECO:0000269|PubMed:7607555}.
CC   -!- DOMAIN: The N-terminal domain of JAKs mediates their interaction with
CC       cytokine/interferon/growth hormone receptors. Possesses 2 protein
CC       kinase domains. The second one probably contains the catalytic domain,
CC       while the presence of slight differences suggest a different role for
CC       protein kinase 1 (By similarity). {ECO:0000250}.
CC   -!- PTM: Autophosphorylated, leading to regulate its activity. Leptin
CC       promotes phosphorylation on tyrosine residues, including
CC       phosphorylation on Tyr-813. Autophosphorylation on Tyr-119 in response
CC       to EPO down-regulates its kinase activity. Autophosphorylation on Tyr-
CC       868, Tyr-966 and Tyr-972 in response to growth hormone (GH) are
CC       required for maximal kinase activity. Also phosphorylated by TEC (By
CC       similarity). Phosphorylated on tyrosine residues in response to
CC       interferon gamma signaling. Phosphorylated on tyrosine residues in
CC       response to a signaling cascade that is activated by increased cellular
CC       retinol (By similarity). {ECO:0000250|UniProtKB:O60674,
CC       ECO:0000250|UniProtKB:Q62120}.
CC   -!- PTM: Undergoes Notch-induced ubiquitination and subsequent proteasomal
CC       degradation which is mediated by ASB1 or ASB2, the substrate-
CC       recognition components of probable ECS E3 ubiquitin-protein ligase
CC       complexes. {ECO:0000250|UniProtKB:O60674}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. JAK subfamily. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U13396; AAA79911.1; -; mRNA.
DR   PIR; JC4127; JC4127.
DR   RefSeq; NP_113702.1; NM_031514.1.
DR   AlphaFoldDB; Q62689; -.
DR   SMR; Q62689; -.
DR   BioGRID; 246670; 9.
DR   DIP; DIP-491N; -.
DR   IntAct; Q62689; 3.
DR   MINT; Q62689; -.
DR   STRING; 10116.ENSRNOP00000071877; -.
DR   BindingDB; Q62689; -.
DR   ChEMBL; CHEMBL1075225; -.
DR   DrugCentral; Q62689; -.
DR   iPTMnet; Q62689; -.
DR   PhosphoSitePlus; Q62689; -.
DR   PaxDb; 10116-ENSRNOP00000021218; -.
DR   Ensembl; ENSRNOT00000087011.2; ENSRNOP00000071877.1; ENSRNOG00000059968.2.
DR   Ensembl; ENSRNOT00055053783; ENSRNOP00055044502; ENSRNOG00055031013.
DR   Ensembl; ENSRNOT00060053416; ENSRNOP00060044381; ENSRNOG00060030737.
DR   GeneID; 24514; -.
DR   KEGG; rno:24514; -.
DR   UCSC; RGD:2939; rat.
DR   AGR; RGD:2939; -.
DR   CTD; 3717; -.
DR   RGD; 2939; Jak2.
DR   eggNOG; KOG0197; Eukaryota.
DR   GeneTree; ENSGT00940000155640; -.
DR   HOGENOM; CLU_008155_1_0_1; -.
DR   InParanoid; Q62689; -.
DR   OMA; FMKLHEN; -.
DR   OrthoDB; 1614410at2759; -.
DR   PhylomeDB; Q62689; -.
DR   BRENDA; 2.7.10.2; 5301.
DR   Reactome; R-RNO-1059683; Interleukin-6 signaling.
DR   Reactome; R-RNO-110056; MAPK3 (ERK1) activation.
DR   Reactome; R-RNO-112411; MAPK1 (ERK2) activation.
DR   Reactome; R-RNO-1170546; Prolactin receptor signaling.
DR   Reactome; R-RNO-1433557; Signaling by SCF-KIT.
DR   Reactome; R-RNO-512988; Interleukin-3, Interleukin-5 and GM-CSF signaling.
DR   Reactome; R-RNO-5673000; RAF activation.
DR   Reactome; R-RNO-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-RNO-6785807; Interleukin-4 and Interleukin-13 signaling.
DR   Reactome; R-RNO-6788467; IL-6-type cytokine receptor ligand interactions.
DR   Reactome; R-RNO-69231; Cyclin D associated events in G1.
DR   Reactome; R-RNO-877300; Interferon gamma signaling.
DR   Reactome; R-RNO-877312; Regulation of IFNG signaling.
DR   Reactome; R-RNO-8854691; Interleukin-20 family signaling.
DR   Reactome; R-RNO-8984722; Interleukin-35 Signalling.
DR   Reactome; R-RNO-9006335; Signaling by Erythropoietin.
DR   Reactome; R-RNO-9020591; Interleukin-12 signaling.
DR   Reactome; R-RNO-9020933; Interleukin-23 signaling.
DR   Reactome; R-RNO-9020956; Interleukin-27 signaling.
DR   Reactome; R-RNO-9027276; Erythropoietin activates Phosphoinositide-3-kinase (PI3K).
DR   Reactome; R-RNO-9027284; Erythropoietin activates RAS.
DR   Reactome; R-RNO-912526; Interleukin receptor SHC signaling.
DR   Reactome; R-RNO-9674555; Signaling by CSF3 (G-CSF).
DR   Reactome; R-RNO-9705462; Inactivation of CSF3 (G-CSF) signaling.
DR   Reactome; R-RNO-9732724; IFNG signaling activates MAPKs.
DR   Reactome; R-RNO-982772; Growth hormone receptor signaling.
DR   Reactome; R-RNO-983231; Factors involved in megakaryocyte development and platelet production.
DR   PRO; PR:Q62689; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000059968; Expressed in thymus and 20 other cell types or tissues.
DR   GO; GO:0005901; C:caveola; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005856; C:cytoskeleton; IEA:InterPro.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0012505; C:endomembrane system; IEA:UniProtKB-SubCell.
DR   GO; GO:0000791; C:euchromatin; IDA:RGD.
DR   GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; ISO:RGD.
DR   GO; GO:0019897; C:extrinsic component of plasma membrane; ISO:RGD.
DR   GO; GO:0005925; C:focal adhesion; IEA:Ensembl.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0030526; C:granulocyte macrophage colony-stimulating factor receptor complex; ISO:RGD.
DR   GO; GO:0045121; C:membrane raft; ISO:RGD.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0098794; C:postsynapse; IDA:SynGO.
DR   GO; GO:0033130; F:acetylcholine receptor binding; IPI:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005131; F:growth hormone receptor binding; IPI:BHF-UCL.
DR   GO; GO:0020037; F:heme binding; ISS:UniProtKB.
DR   GO; GO:0042393; F:histone binding; ISS:UniProtKB.
DR   GO; GO:0035401; F:histone H3Y41 kinase activity; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0043560; F:insulin receptor substrate binding; IPI:RGD.
DR   GO; GO:0005143; F:interleukin-12 receptor binding; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IBA:GO_Central.
DR   GO; GO:0051428; F:peptide hormone receptor binding; IPI:RGD.
DR   GO; GO:0043548; F:phosphatidylinositol 3-kinase binding; IPI:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IMP:RGD.
DR   GO; GO:0042169; F:SH2 domain binding; ISO:RGD.
DR   GO; GO:0005102; F:signaling receptor binding; ISO:RGD.
DR   GO; GO:0031702; F:type 1 angiotensin receptor binding; IPI:RGD.
DR   GO; GO:0042976; P:activation of Janus kinase activity; ISS:UniProtKB.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0031103; P:axon regeneration; IMP:RGD.
DR   GO; GO:0030154; P:cell differentiation; ISO:RGD.
DR   GO; GO:0007259; P:cell surface receptor signaling pathway via JAK-STAT; IDA:RGD.
DR   GO; GO:0071549; P:cellular response to dexamethasone stimulus; ISO:RGD.
DR   GO; GO:0036016; P:cellular response to interleukin-3; ISO:RGD.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; ISO:RGD.
DR   GO; GO:0038065; P:collagen-activated signaling pathway; ISO:RGD.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0007167; P:enzyme-linked receptor protein signaling pathway; ISO:RGD.
DR   GO; GO:0030218; P:erythrocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0097191; P:extrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IMP:RGD.
DR   GO; GO:0038157; P:granulocyte-macrophage colony-stimulating factor signaling pathway; ISO:RGD.
DR   GO; GO:0060396; P:growth hormone receptor signaling pathway; ISO:RGD.
DR   GO; GO:0060397; P:growth hormone receptor signaling pathway via JAK-STAT; IDA:RGD.
DR   GO; GO:0009755; P:hormone-mediated signaling pathway; IDA:RGD.
DR   GO; GO:0035722; P:interleukin-12-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0038156; P:interleukin-3-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0038043; P:interleukin-5-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; ISO:RGD.
DR   GO; GO:0008631; P:intrinsic apoptotic signaling pathway in response to oxidative stress; IMP:RGD.
DR   GO; GO:0061180; P:mammary gland epithelium development; ISO:RGD.
DR   GO; GO:0001774; P:microglial cell activation; ISO:RGD.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; IDA:SynGO.
DR   GO; GO:0030099; P:myeloid cell differentiation; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0010667; P:negative regulation of cardiac muscle cell apoptotic process; IMP:RGD.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0022408; P:negative regulation of cell-cell adhesion; IMP:RGD.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IMP:RGD.
DR   GO; GO:0031959; P:nuclear receptor-mediated mineralocorticoid signaling pathway; IMP:RGD.
DR   GO; GO:0048008; P:platelet-derived growth factor receptor signaling pathway; IMP:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:RGD.
DR   GO; GO:2001235; P:positive regulation of apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0050867; P:positive regulation of cell activation; IMP:RGD.
DR   GO; GO:0045597; P:positive regulation of cell differentiation; IMP:RGD.
DR   GO; GO:0030335; P:positive regulation of cell migration; IMP:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:RGD.
DR   GO; GO:0010811; P:positive regulation of cell-substrate adhesion; ISO:RGD.
DR   GO; GO:0120162; P:positive regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IMP:RGD.
DR   GO; GO:1904037; P:positive regulation of epithelial cell apoptotic process; IMP:RGD.
DR   GO; GO:1902728; P:positive regulation of growth factor dependent skeletal muscle satellite cell proliferation; IMP:RGD.
DR   GO; GO:0060399; P:positive regulation of growth hormone receptor signaling pathway; ISO:RGD.
DR   GO; GO:0032024; P:positive regulation of insulin secretion; IMP:RGD.
DR   GO; GO:0032731; P:positive regulation of interleukin-1 beta production; IMP:RGD.
DR   GO; GO:0070665; P:positive regulation of leukocyte proliferation; ISO:RGD.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; IMP:RGD.
DR   GO; GO:0045348; P:positive regulation of MHC class II biosynthetic process; ISO:RGD.
DR   GO; GO:0032819; P:positive regulation of natural killer cell proliferation; ISO:RGD.
DR   GO; GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IMP:RGD.
DR   GO; GO:0051770; P:positive regulation of nitric-oxide synthase biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0051142; P:positive regulation of NK T cell proliferation; ISO:RGD.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0010572; P:positive regulation of platelet activation; ISO:RGD.
DR   GO; GO:1901731; P:positive regulation of platelet aggregation; ISO:RGD.
DR   GO; GO:0042307; P:positive regulation of protein import into nucleus; IMP:RGD.
DR   GO; GO:0046427; P:positive regulation of receptor signaling pathway via JAK-STAT; ISO:RGD.
DR   GO; GO:0060391; P:positive regulation of SMAD protein signal transduction; ISO:RGD.
DR   GO; GO:0042102; P:positive regulation of T cell proliferation; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0032760; P:positive regulation of tumor necrosis factor production; ISO:RGD.
DR   GO; GO:0032729; P:positive regulation of type II interferon production; ISO:RGD.
DR   GO; GO:0042531; P:positive regulation of tyrosine phosphorylation of STAT protein; ISS:UniProtKB.
DR   GO; GO:1904707; P:positive regulation of vascular associated smooth muscle cell proliferation; IMP:RGD.
DR   GO; GO:0035166; P:post-embryonic hemopoiesis; ISO:RGD.
DR   GO; GO:0043687; P:post-translational protein modification; ISS:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; ISS:UniProtKB.
DR   GO; GO:0042981; P:regulation of apoptotic process; IBA:GO_Central.
DR   GO; GO:0050727; P:regulation of inflammatory response; ISO:RGD.
DR   GO; GO:0045428; P:regulation of nitric oxide biosynthetic process; IGI:ARUK-UCL.
DR   GO; GO:1905539; P:regulation of postsynapse to nucleus signaling pathway; IDA:SynGO.
DR   GO; GO:0014075; P:response to amine; IEP:RGD.
DR   GO; GO:0046677; P:response to antibiotic; ISO:RGD.
DR   GO; GO:0033194; P:response to hydroperoxide; IMP:RGD.
DR   GO; GO:0070671; P:response to interleukin-12; ISO:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; ISO:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0006979; P:response to oxidative stress; IMP:RGD.
DR   GO; GO:0034612; P:response to tumor necrosis factor; ISO:RGD.
DR   GO; GO:0007165; P:signal transduction; ISS:UniProtKB.
DR   GO; GO:0034050; P:symbiont-induced defense-related programmed cell death; ISO:RGD.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0033209; P:tumor necrosis factor-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0060333; P:type II interferon-mediated signaling pathway; IDA:BHF-UCL.
DR   CDD; cd14473; FERM_B-lobe; 1.
DR   CDD; cd13333; FERM_C_JAK2; 1.
DR   CDD; cd05078; PTK_Jak2_rpt1; 1.
DR   CDD; cd14205; PTKc_Jak2_rpt2; 1.
DR   CDD; cd10379; SH2_Jak2; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1.
DR   Gene3D; 3.30.505.10; SH2 domain; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 2.
DR   InterPro; IPR019749; Band_41_domain.
DR   InterPro; IPR035963; FERM_2.
DR   InterPro; IPR019748; FERM_central.
DR   InterPro; IPR000299; FERM_domain.
DR   InterPro; IPR041155; FERM_F1.
DR   InterPro; IPR041046; FERM_F2.
DR   InterPro; IPR051286; JAK.
DR   InterPro; IPR041381; JAK1-3/TYK2_PHL_dom.
DR   InterPro; IPR037838; JAK2_FERM_C-lobe.
DR   InterPro; IPR035860; JAK2_SH2.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR035588; PTK_Jak2_rpt1.
DR   InterPro; IPR035589; PTKc_Jak2_rpt2.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR016251; Tyr_kinase_non-rcpt_Jak/Tyk2.
DR   InterPro; IPR020693; Tyr_kinase_non-rcpt_Jak2.
DR   PANTHER; PTHR45807; TYROSINE-PROTEIN KINASE HOPSCOTCH; 1.
DR   PANTHER; PTHR45807:SF1; TYROSINE-PROTEIN KINASE JAK2; 1.
DR   Pfam; PF18379; FERM_F1; 1.
DR   Pfam; PF18377; FERM_F2; 1.
DR   Pfam; PF17887; Jak1_Phl; 1.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 2.
DR   Pfam; PF21990; SH2_1; 1.
DR   PIRSF; PIRSF000636; TyrPK_Jak; 1.
DR   PRINTS; PR01823; JANUSKINASE.
DR   PRINTS; PR01825; JANUSKINASE2.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00295; B41; 1.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00219; TyrKc; 2.
DR   SUPFAM; SSF50729; PH domain-like; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 2.
DR   SUPFAM; SSF47031; Second domain of FERM; 1.
DR   SUPFAM; SSF55550; SH2 domain; 1.
DR   PROSITE; PS50057; FERM_3; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 2.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS50001; SH2; 1.
PE   1: Evidence at protein level;
KW   Adaptive immunity; ATP-binding; Chromatin regulator; Cytoplasm; Immunity;
KW   Innate immunity; Kinase; Magnesium; Membrane; Metal-binding;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   SH2 domain; Transferase; Tyrosine-protein kinase; Ubl conjugation.
FT   CHAIN           1..1132
FT                   /note="Tyrosine-protein kinase JAK2"
FT                   /id="PRO_0000088114"
FT   DOMAIN          37..380
FT                   /note="FERM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00084"
FT   DOMAIN          401..482
FT                   /note="SH2; atypical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00191"
FT   DOMAIN          545..809
FT                   /note="Protein kinase 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          849..1126
FT                   /note="Protein kinase 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..239
FT                   /note="Interaction with cytokine/interferon/growth hormone
FT                   receptors"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        976
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   BINDING         855..863
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         882
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         119
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q62120"
FT   MOD_RES         372
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q62120"
FT   MOD_RES         373
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q62120"
FT   MOD_RES         523
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         570
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:O60674"
FT   MOD_RES         813
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q62120"
FT   MOD_RES         868
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q62120"
FT   MOD_RES         966
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q62120"
FT   MOD_RES         972
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q62120"
FT   MOD_RES         1007
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:O60674"
FT   MOD_RES         1008
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:O60674"
SQ   SEQUENCE   1132 AA;  130585 MW;  C3AEDF2FECE8B95A CRC64;
     MGMACLTMTE MEGTSTSPAH QNGDIPGNAN SVKQTEPVLQ VYLYHSLGQA EGDYLKFPNG
     EYVAEEICVA ASKACGITPV YHNMFALMSE TERIWYPPNH VFHIDESTRH NILYRIRFYF
     PHWYCSGSNR TYRYGVSRGA EAPLLDDFVM SYLFAQWRHD FVHGWIKVPV THETQEECLG
     MAVLDMMRIA KEKDQTPLAV YNSISYKTFL PKCVRAKIQD YHILTRKRIR YRFRRFIQQF
     SQCKATARNL KLKYLINLET LQSAFYTEQF EVKESARGPS GEEIFATIII TGNGGIQWSR
     GKHKESETLT EQDLQLYCDF PDIIDVSIKQ ANQECSTESR VVTVHKQDGK VLEIELSSLK
     EALSFVSLID GYYRLTADAH HYLCKEVAPP AVLENIHSNC HGPISMDFAI SKLKKAGNQT
     GLYVLRCSPK DFNKYFLTFA VERENVIEYK HCLITKNENG EYNLSGTKRN FSSLKDLLNC
     YQMETVRSDS IIFQFTKCCP PKPKDKSNLL VFRTNGVSDV QLSPTLQRHN NVNQMVFHKI
     RNEDLIFNES LGQGTFTKIF KGVRREVGDY GQLHETEVLL KVLDKAHRNY SESFFEAASM
     MSQLSHKHLV LNYGVCVCGE ENILVQEFVK FGSLDTYLKK NKNSINILWK LGVAKQLAWA
     MHFLEEKSLI HGNVCAKNIL LIREEDRKTG NPPFIKLSDP GISITVLPKD ILQERIPWVP
     PECIENPKNL TLATDKWSFG TTLWEICSGG DKPLSALDSQ RKLQFYEDKH QLPAPKWTEL
     ANLINTCMDY EPDFRPAFRA VIRDLNSLFT PDYELLTEND MLPNMRIGAL GFSGAFEDRD
     PTQFEERHLK FLQQLGKGNF GSVEMCRYDP LQDNTGEVVA VKKLQHSTEE HLRDFEREIE
     ILKSLQHDNI VKYKGVCYSA GRRNLRLIME YLPYGSLRDY LQKHKERIDH KKLLQYTSQI
     CKGMEYLGTK RYIHRDLATR NILVENENRV KIGDFGLTKV LPQDKEYYKV KEPGESPIFW
     YAPESLTESK FSVASDVWSF GVVLYELFTY IEKSKSPPVE FMRMIGNDKQ GQMIVFHLIE
     LLKNNGRLPR PEGCPDEIYV IMTECWNNNV NQRPSFRDLS LRVDQIRDSM AA
//
